We are live on ! Find out more
PSC

Patient Square Capital Portfolio holdings

AUM $564M
1-Year Est. Return 261.3%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+261.3%
3 Year Est. Return
+328.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$236M
AUM Growth
–
Cap. Flow
+$241M
Cap. Flow %
102.03%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EAR
Eargo, Inc. Common Stock
EAR
+$203M
2
ROIV icon
Roivant Sciences
ROIV
+$38M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EAR
1
DELISTED
Eargo, Inc. Common Stock
EAR
$182M 76.94%
+15,821,299
New +$203M
ROIV icon
2
Roivant Sciences
ROIV
$24.1B
$54.5M 23.06%
+6,825,967
New +$38M

Similar funds

TCP
ThornTree Capital Partners Boston, Massachusetts $564M AUM 36.37% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
KF
KKM Financial Chicago, Illinois $563M AUM 28.2% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AAS
Asset Allocation Strategies Farmington, Michigan $563M AUM 15.65% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $563M AUM 20.97% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $565M AUM

Patient Square Capital's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Patient Square Capital, which disclosed 2 positions worth $236M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Eargo, Inc. Common Stock: 15,821,299 shares worth $182M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Patient Square Capital's largest Q4 2022 buy was Eargo, Inc. Common Stock: 15,821,299 shares worth $182M.
  • Patient Square Capital's ten largest holdings make up 100% of its $236M portfolio in Q4 2022.
  • Patient Square Capital disclosed 2 positions in Q4 2022, its first 13F filing on record.

Based on Patient Square Capital's 13F filing for Q4 2022, filed 13 Feb 2023.